Month: June 2023

20230626_Alpine F1 Team_Press Release_EN ALPINE RACING LTD SPEEDS UP ITS DEVELOPMENT AND ATTRACTS €200M FROM WORLD CLASS INVESTORS Renault Group and Alpine welcome Otro Capital, RedBird Capital Partners and Maximum Effort Investments to Alpine Racing Ltd, with a 24% equity stake.Renault Group and Alpine welcome Otro Capital and their partner, RedBird Capital Partners, along with Maximum Effort Investments (together, the “Investor Group”) to Alpine Racing Ltd, the entity in charge of Formula 1 activities based in Enstone (UK). The Investor Group is investing €200 million, representing a 24% equity stake, to support Alpine’s growth strategy and sporting ambitions in Formula 1. The transaction values Alpine Racing Ltd around $900 million following this investment. The Investor Group brings together a unique combination of expertise. Otro...

VANCOUVER, British Columbia and SYDNEY, Australia, June 26, 2023 (GLOBE NEWSWIRE) — Patriot Battery Metals Inc. (the “Company” or “Patriot”) (TSX-V: PMET) (ASX: PMT) (OTCQX: PMETF) (FSE: R9GA) notes that the article in the Australian Newspaper of today (Patriot Battery Metals taps Macquarie Capital for a deal) and provides the following clarifying statement:The Company has not commenced a process that would have the effect of initiating a sale of any of its assets, nor the listed parent. The Company has appointed a range of advisers and key personnel that further supports the continued development of its flagship wholly owned Corvette Property. The Company remains intently focused on the timely development of the Corvette Property, including the presentation of the Mineral Resource Estimate (“MRE”) at the Corvette Property in...

Company will Host Conference Call to Discuss the Transaction on June 26 at 8:30 a.m. EDTPrenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening (Prof. Dennis Lo and Danny Yeung at Signing Ceremony)(Prof. Dennis Lo and Danny Yeung at Signing Ceremony) – Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo. – Insighta is powered by technology developed by the Centre for Novostics which is supported by the InnoHK Initiative of the Innovation and Technology Commission of the Hong Kong SAR Government. – By 2030, the early cancer detection screening opportunity is estimated to be US$6bn in Asia on an annual basis.1 – Prof. Dennis Lo is the Li Ka Shing Professor of Medicine of the Chinese University...

Press ReleaseJune 25, 2023 – N° 14 Fabrice Brégier is appointed Chairmanof SCOR’s Board of Directors SCOR’s Board of Directors, which met on June 25, 2023, has unanimously decided to appoint Fabrice Brégier non-executive Chairman, with immediate effect. This decision was made on the unanimous recommendation of the Nomination Committee, at the conclusion of a demanding and rigorous succession process initiated in spring 2022. Over the months since the process began, the Nomination Committee, assisted by the international recruitment firm Egon Zehnder, has met on numerous occasions to define the search criteria for the future Chairman, to select first-rate individuals who could match the expected profile, and finally to meet the candidates most likely to take the helm of the Board. The Committee, chaired by Adrien Couret, ultimately...

  ALTUVIIIOTM late-breaking data at ISTH demonstrates highly effective bleed protection in children with severe hemophilia A with once-weekly dosingXTEND-Kids data confirm the efficacy and safety profile of ALTUVIIIO with simple, weekly 50 IU/kg dosing for both adults and children ALTUVIIIO’s expanding evidence of a first and best-in-class profile supports Sanofi’s commitment to delivering paradigm shifting therapies for Rare DiseasesParis, June 25, 2023. Pivotal data from the Phase 3 XTEND-Kids study evaluating ALTUVIIIOTM [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein] once-weekly prophylaxis, a first-in-class, high-sustained factor VIII replacement therapy, in previously treated patients younger than 12 years of age with severe hemophilia A were presented today in a late-breaking session at the Annual Meeting of...

MoonLake Immunotherapeutics achieves landmark milestone with positive Phase 2 results for Nanobody® sonelokimab in hidradenitis suppurativaFirst placebo-controlled randomized trial in HS to report positive topline results using HiSCR75 as the primary endpoint Primary endpoint HiSCR75 met with 29 percentage points (ppt) delta vs placebo (p=0.0002) at week 12, setting a new bar in HS HiSCR50 met with 38 ppt delta vs placebo (p

                                                          Communiqué vidéo de Patrick MARCHE et Bernard VOISIN NEOLIFE® (Euronext Growth : FR0011636083 – ALNLF), (la « Société ») annonce partager un communiqué vidéo de Patrick MARCHE et Bernard VOISIN, respectivement Président du Conseil de Surveillance et Président du Directoire de la Société. Communiqué vidéo Patrick MARCHE et Bernard VOISIN La Société rappelle toujours se tenir à disposition des actionnaires via l’adresse mail investors@neolife.fr pour répondre à leurs questions en amont de l’assemblée générale du 26 juin. CONTACTNEOLIFE®investors@neolife.frAttachmentCP NEOLIFE 25 JUIN 2023 – Vidéo Direction

VEON publishes audited financial statements for year ended 31 December 2022 Amsterdam, 25 June 2023 – VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides connectivity and online services (“VEON” or the “Company” or, together with its subsidiaries, the “Group”), today announces that it has published its Dutch Annual Report – 2022, including consolidated financial statements for the year ended 31 December 2022 prepared in accordance with International Financial Reporting Standards as adopted by the European Union and with Part 9 of Book 2 of the Dutch Civil Code (the “Consolidated Financial Statements). A copy of the Dutch Annual Report – 2022 can be found on the Reports and Results section of the Company’s website at https://www.veon.com/investors/reports-results/. The Consolidated Financial Statements...